• Search Funds
  • Model Portfolios
  • Provider
  • Sector
  • Manager

Search by provider name

Search by sector name

Search by manager name

Search by Risk Level

M&G Positive Impact Fund I Inc

  • Fund Info & charges
  • Performance
  • Fund breakdown
  • Dividend History
Fund ProviderM&G Securities Ltd
Fund SummaryThe Fund has two aims. To provide a higher total return (the combination of capital growth and income), net of the Ongoing Charges Figure, than the MSCI ACWI Index over any five-year period; and to invest in companies that aim to have a positive societal impact through addressing the world's major social and environmental challenges.
SEDOL codeBG886C1
Fund codeMGPII
ManagersJohn Olsen, Michael Oliveros
Manager Tenure2 years
Morningstar CategoryGlobal Large-Cap Growth Equity
IMA SectorGlobal
Fund Size£105 million
Fund TypeOEIC
Management StyleActive
Ongoing Charge Figure (OCF)0.85%
Cavendish ongoing charge0.05%
FundsNetwork Service Fee0.20%
Minimum Initial Investment£25
Minimum Top Up£25
Minimum Monthly Investment£25
Sell Price£1.2677
Buy Price£1.2677
Price Change-1.2463%
Price Date24th September 2020
YieldCurrently unavailable
Dividend FrequencySemi-Annually
ISA EligibleYes
SIPP EligibleYes
Inception Date28th January 2019
Fund StatusOPEN
John William Olsen joined M&G in April 2014, and was appointed FM of the Eastspring Pan European Fund, M&G Global Select Fund and M&G Pan European Select Fund in July 2014. He was later appointed deputy manager of the M&G Pan European Select Smaller Companies Fund in July 2016. He joined Danske Capital in 1998 as a FM in domestic Danish equities, and in 2000 also became a global sector analyst focusing on technology and telecommunications. From 2002 he managed non-domestic equity. He has a BA in business economics and a MSc in finance and accounting from Copenhagen Business School.

3-year Mean Monthly Return: Currently unavailable

Annual Returns2019
Fund Performance+8.32%
Benchmark Performance
(Global Large-Cap Growth Equity)
Time PeriodCumulativeBenchmark Performance
(Global Large-Cap Growth Equity)
Fund Compared to Benchmark
1 day-1.25%+13.54%-14.79%
1 week-1.51%-0.83%-0.68%
1 month-1.70%+4.28%-5.97%
3 months2.06%+32.15%-30.09%
6 months26.67%+16.26%+10.41%
1 year8.85%+17.57%-8.72%
3 yearsCurrently unavailableCurrently unavailableCurrently unavailable
5 yearsCurrently unavailableCurrently unavailableCurrently unavailable
10 yearsCurrently unavailableCurrently unavailableCurrently unavailable
Since inception14.99%Currently unavailableCurrently unavailable

Top 10 shares for this fund

Share NameCountryValue
Orsted A/SDNK5.13%
SolarEdge Technologies IncUSA4.77%
Ansys IncUSA4.36%
Novo Nordisk A/S BDNK4.29%
Alk-Abello A/S BDNK3.95%
Fresenius Medical Care AG & Co. KGaADEU3.80%
UnitedHealth Group IncUSA3.74%
Thermo Fisher Scientific IncUSA3.66%
Rockwool International A/S BDNK3.57%
Illumina IncUSA3.51%
Dividend DatePer share amountReinvestment Price
1st April 20200.0172£1.0061
1st April 20190.0038£1.0610